PureTech sells shares in Karuna affiliate for $200m
PureTech Health
218.00p
16:40 26/04/24
2.59%
5.50p
Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.
FTSE 250
19,824.16
16:59 26/04/24
n/a
n/a
FTSE 350
4,470.09
16:59 26/04/24
n/a
n/a
FTSE All-Share
4,423.59
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
PureTech Health said it intended to use the cash to fund operations and advance its clinical stage, wholly-owned pipeline.
The company on Thursday said it would still hold a 20.4% stake in Karuna's and a right to royalty payments on net sales of any commercialised product covered by a license granted by PureTech to Karuna.